science 🔬 Indian scientists create smart cancer drug candidate
Indian scientists have developed a new smart cancer drug candidate, RK-251, aiming for targeted treatment. The research involved Dr Asis Bala from IASST and Dr K.P. Bhabak from IIT Guwahati. RK-251 is designed to activate inside cancer cells by reacting to high levels of reactive oxygen species (ROS). This mechanism helps overcome side effects by selectively targeting cancer cells, as shown in preclinical tests. Further lab studies and clinical trials are required before it can be used on humans. 🔬